Lodestar Private Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,341
Closed -$233K 217
2024
Q4
$233K Hold
2,341
0.03% 201
2024
Q3
$266K Sell
2,341
-86
-4% -$10.2K 0.03% 192
2024
Q2
$300K Sell
2,427
-65
-3% -$8.37K 0.04% 173
2024
Q1
$329K Buy
2,492
+26
+1% +$3.21K 0.05% 166
2023
Q4
$269K Sell
2,466
-29
-1% -$3.01K 0.04% 176
2023
Q3
$257K Sell
2,495
-201
-7% -$21.7K 0.04% 170
2023
Q2
$311K Buy
2,696
+105
+4% +$11.9K 0.05% 156
2023
Q1
$276K Hold
2,591
0.05% 162
2022
Q4
$287K Buy
+2,591
New +$265K 0.06% 158

Other funds holding MRK

Lodestar Private Asset Management's MRK Position: Q1 2025 in Review

Lodestar Private Asset Management sold out of Merck (MRK) in Q1 2025, closing a stake of 2,341 shares — an estimated $233K sold.

Lodestar Private Asset Management first reported a position in MRK in Q4 2022 and held it in 9 quarters. The position peaked at $329K in Q1 2024. 3,447 funds tracked by Wall St. Rank hold MRK as of Q1 2025.

  • Lodestar Private Asset Management reported no remaining Merck position as of Q1 2025 after selling out during the quarter.
  • Lodestar Private Asset Management sold 2,341 Merck shares in Q1 2025, an estimated $233K.
  • Lodestar Private Asset Management first reported a position in Merck in Q4 2022 and held it in 9 quarters.
  • Lodestar Private Asset Management's Merck position peaked at $329K in Q1 2024.
  • 3,447 funds tracked by Wall St. Rank held Merck as of Q1 2025.

Based on Lodestar Private Asset Management's 13F filing for Q1 2025, filed 25 Apr 2025.